DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/w6pf2m/menopausal_hot) has announced the addition of the "Menopausal Hot Flashes - Pipeline Review, H2 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Menopausal Hot Flashes, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
Pherin Pharmaceuticals is a California-based drug development company that develops pherines for the treatment of neuropsychiatric and neuroendocrine conditions.